Allogene Therapeutics (ALLO) stock forecast for 2024. Forecast tables and graphs.

Allogene Therapeutics (ALLO) stock forecast for 2024

The forecast has been updated: September 13, 2021 12:50


Allogene Therapeutics stock price online today

Analyst Target Price

48.57

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Allogene Therapeutics stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Allogene Therapeutics stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $48.57 target price for Allogene Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (27.95 $).

50 Day Moving Average is the support level (23.16 $).




ALLO Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 29.30 27.31 30.62 10.81 %
Feb 29.53 27.82 30.74 9.51 %
Mar 30.09 28.32 31.60 10.38 %
Apr 27.09 25.73 27.82 7.50 %
May 25.81 25.04 27.80 9.94 %
Jun 28.26 26.48 29.51 10.25 %
Jul 29.20 27.50 30.10 8.63 %
Aug 27.83 27.13 29.72 8.71 %
Sep 27.63 26.77 29.15 8.15 %
Oct 26.36 24.88 27.31 8.88 %
Nov 25.49 24.65 26.08 5.47 %
Dec 24.70 23.64 26.13 9.55 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Allogene Therapeutics stock.


Allogene Therapeutics overview

Allogene Therapeutics Address

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Market Capitalization

3 517 608 000 $

EBITDA

-134 911 008

PE Ratio

None

PEG Ratio

None

Dividend Per Share

None

Dividend Yield

0

EPS

-1.822

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

0

Forward PE

0

EV To Revenue

77.66

EV To EBITDA

0

52 Week High

44.92

52 Week Low

20.58

50 Day Moving Average

23.16

200 Day Moving Average

27.95

Shares Outstanding

142183000

Shares Float

74538000

Shares Short Prior Month

8376600

Short Ratio

13.13

Percent Insiders

34.73

Percent Institutions

61.45

Allogene Therapeutics stock forecast for this year


Allogene Therapeutics stock forecast for Jan 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 29.30. Positive monthly dynamics of the instrument is expected with 10.813% volatility is expected.

Pessimistic forecast: 27.31

Optimistic: 30.62


Allogene Therapeutics stock forecast for Feb 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 29.53. Positive monthly dynamics of the instrument is expected with 9.510% volatility is expected.

Pessimistic forecast: 27.82

Optimistic: 30.74


Allogene Therapeutics stock forecast for Mar 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 30.09. Positive monthly dynamics of the instrument is expected with 10.381% volatility is expected.

Pessimistic forecast: 28.32

Optimistic: 31.60


Allogene Therapeutics stock forecast for Apr 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 27.09. Negative monthly dynamics of the instrument is expected with 7.498% volatility is expected.

Pessimistic forecast: 25.73

Optimistic: 27.82


Allogene Therapeutics stock forecast for May 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 25.81. Negative monthly dynamics of the instrument is expected with 9.935% volatility is expected.

Pessimistic forecast: 25.04

Optimistic: 27.80


Allogene Therapeutics stock forecast for Jun 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 28.26. Positive monthly dynamics of the instrument is expected with 10.249% volatility is expected.

Pessimistic forecast: 26.48

Optimistic: 29.51


Allogene Therapeutics stock forecast for Jul 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 29.20. Positive monthly dynamics of the instrument is expected with 8.632% volatility is expected.

Pessimistic forecast: 27.50

Optimistic: 30.10


Allogene Therapeutics stock forecast for Aug 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 27.83. Negative monthly dynamics of the instrument is expected with 8.708% volatility is expected.

Pessimistic forecast: 27.13

Optimistic: 29.72


Allogene Therapeutics stock forecast for Sep 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 27.63. Negative monthly dynamics of the instrument is expected with 8.152% volatility is expected.

Pessimistic forecast: 26.77

Optimistic: 29.15


Allogene Therapeutics stock forecast for Oct 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 26.36. Negative monthly dynamics of the instrument is expected with 8.880% volatility is expected.

Pessimistic forecast: 24.88

Optimistic: 27.31


Allogene Therapeutics stock forecast for Nov 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 25.49. Negative monthly dynamics of the instrument is expected with 5.474% volatility is expected.

Pessimistic forecast: 24.65

Optimistic: 26.08


Allogene Therapeutics stock forecast for Dec 2024.
Estimated Average Forecasted Allogene Therapeutics Price: 24.70. Negative monthly dynamics of the instrument is expected with 9.546% volatility is expected.

Pessimistic forecast: 23.64

Optimistic: 26.13



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 127.44 (16.09.2021) -0.04 %
AbbVie Inc.
ABBV 108.08 (16.09.2021) 0.29 %
Aeterna Zentaris Inc.
AEZS 0.6188 (15.09.2021) -3.12 %
Allakos Inc.
ALLK 108.23 (15.09.2021) 1.13 %
Allogene Therapeutics, Inc.
ALLO 25 (15.09.2021) 0.56 %
Amgen Inc.
AMGN 217.36 (16.09.2021) -0.35 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.9 (15.09.2021) 1.53 %
Aurora Cannabis Inc.
ACB 6.68 (15.09.2021) 2.77 %
Becton Dickinson and Company
BDX 262.67 (16.09.2021) 0.38 %
Biogen Inc.
BIIB 299.69 (16.09.2021) 0.16 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 136.93 (16.09.2021) 0.69 %
BioNTech SE
BNTX 372.65 (16.09.2021) 4.90 %
bluebird bio, Inc.
BLUE 17.8 (15.09.2021) 1.37 %
Boston Scientific Corp.
BSX 44.9 (16.09.2021) -0.24 %
Bristol-Myers Squibb Company
BMY 61.23 (16.09.2021) -1.24 %
Canopy Growth Corp.
CGC 14.79 (15.09.2021) 1.09 %
Castle Biosciences, Inc.
CSTL 76.21 (16.09.2021) 1.99 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 8.17 (15.09.2021) -1.57 %
Eli Lilly and Company
LLY 231.04 (16.09.2021) -1.15 %
Emergent BioSolutions Inc.
EBS 57.47 (16.09.2021) 0.56 %
Exelixis, Inc.
EXEL 20.54 (16.09.2021) 0.34 %
G1 Therapeutics, Inc.
GTHX 13.94 (15.09.2021) 0.50 %
Gilead Sciences, Inc.
GILD 71.76 (15.09.2021) 1.86 %
GlaxoSmithKline plc
GSK 39.22 (15.09.2021) -0.38 %
GoodRx Holdings, Inc.
GDRX 44.29 (15.09.2021) -0.72 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.04 (16.09.2021) 2.18 %
Inovio Pharmaceuticals, Inc.
INO 7.75 (16.09.2021) 2.38 %
Johnson & Johnson
JNJ 165.22 (16.09.2021) -0.12 %
Medtronic plc.
MDT 130.92 (16.09.2021) -0.55 %
Merck & Co., Inc.
MRK 71.97 (16.09.2021) -1.15 %
Moderna, Inc.
MRNA 434.46 (15.09.2021) 1.58 %
Novartis AG
NVS 85.08 (15.09.2021) -0.23 %
Novavax, Inc.
NVAX 232.3 (15.09.2021) -0.85 %
ObsEva SA
OBSV 3.06 (15.09.2021) 1.66 %
OrganiGram Holdings Inc.
OGI 2.4 (16.09.2021) -0.83 %
Pfizer Inc.
PFE 44.47 (16.09.2021) -0.67 %
Regeneron Pharmaceuticals, Inc.
REGN 653.18 (16.09.2021) 0.18 %
Sanofi
SNY 48.01 (15.09.2021) -0.56 %
Schrodinger, Inc.
SDGR 61.15 (16.09.2021) 0.30 %
Senseonics Holdings, Inc.
SENS 3.87 (15.09.2021) 2.65 %
Sorrento Therapeutics, Inc.
SRNE 7.94 (15.09.2021) 1.28 %
Stryker Corp.
SYK 276.11 (16.09.2021) -0.36 %
Sundial Growers Inc.
SNDL 0.7193 (16.09.2021) -1.44 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.95 (16.09.2021) -0.22 %
Thermo Fisher Scientific Inc.
TMO 560.44 (16.09.2021) -0.45 %
Tilray, Inc.
TLRY 12.01 (16.09.2021) -0.17 %
UnitedHealth Group, Inc.
UNH 416.84 (16.09.2021) -0.16 %
Veeva Systems Inc.
VEEV 305 (16.09.2021) 1.75 %
Zomedica Corp.
ZOM 0.531 (15.09.2021) -2.25 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.32 (16.09.2021) -0.69 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.